
How Your COVID-19 Antibodies Fare Over Time
Antibodies from Pfizer's vaccine rose more slowly and declined more quickly than those generated by Moderna's vaccine.
Antibodies from Pfizer's vaccine rose more slowly and declined more quickly than those generated by Moderna's vaccine.
Our Patrick Jackson, MD, an infectious disease expert, is feeling very optimistic. Read why and learn about how the forthcoming drugs work.
A new announcement from Regeneron Pharmaceuticals could be good news for the immunocompromised.
The vaccine would be easy to store and transport, even in remote corners of the globe, and could be manufactured in bulk using existing vaccine factories. Plus it could cost only about $1 a dose.
Our Bill Petri Jr., MD, PhD, has answers.
The findings underscore the need for vaccination in the battle against COVID-19.